Menu
← Oncology Approval Tracker
FDA DECISION ·
Keytruda
pembrolizumab · Merck Sharp & Dohme
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with relapsed or refractory classical Hodgkin lymphoma and children with refractory disease or relapse after at least two treatment lines.
LAMPGEN ANALYSIS
Why it matters
Converted the accelerated indication to regular approval while widening the adult population.
What research teams should watch
Apply age-specific rules for prior therapy and capture transplant history in eligibility checks.
PRIMARY RECORDS